| Outcome |
---|---|
Feasibility | 1. Participant recruitment rates |
2. Participant retention rate | |
3. Trial resource utilization, costs | |
4. Recommendation acceptance rates by primary team | |
5. Recommendation acceptance rates by patient | |
6. Recommendation adherence rates by patient | |
7. CPT consultation volume capacity | |
8. Potential to intervene entirely virtually (online) | |
Clinical | 1. Medication management outcomes a) # inappropriate medications, # drug therapy problems improved, # high-risk medication problems improved, all measured by APEQ b) # medications per patient end study versus baseline |
2. Adverse drug events including adverse drug withdrawal event | |
3. Medication errors, including preventability | |
4. Patient problems with medications questionnaire (includes general adherence) | |
5. Patient knowledge of medications | |
6. Coordination and continuity of care | |
7. Patient quality of life (EQ-5D-5L and medication-related QOL) | |
8. Satisfaction with care (patients and providers) | |
9. Health resource utilization, including clinical events of death, ED visits, hospitalizations, physician visits, other providers including diagnostics utilization, medication costs |